Company Overview
Snapshot
Founded in March 2014 by Jarret Fass and Sagy Karavany, HemoDynamx operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of medical devices.
Business overview
HemoDynamx is a cardiovascular medical device company specializing in developing treatments for aortic stenosis. The company's core technology is focused on creating a profoundly simple treatment for this condition, serving the healthcare industry, particularly healthcare providers. It operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics.
Log in to access full profile ›Company Intelligence Q&A
- What is HemoDynamx's primary focus?
- HemoDynamx is a cardiovascular medical device company focused on developing a treatment for aortic stenosis.
- When was HemoDynamx founded?
- HemoDynamx was founded in March 2014.
- Who are the founders of HemoDynamx?
- HemoDynamx was co-founded by Jarret Fass and Sagy Karavany.
- In which sector does HemoDynamx primarily operate?
- HemoDynamx primarily operates in the Health Tech & Life Sciences sector, specifically within Medical Devices and Medical Treatment & Therapeutics.
- What is the current product stage of HemoDynamx?
- HemoDynamx's product is currently in the Research & Development (R&D) stage, as of June 2024, focusing on the development of medical devices for aortic stenosis.